Actelion confirms Johnson & Johnson approach

Markets Reuters

A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann (Copyright Reuters 2016)

Actelion has confirmed it has been approached by Johnson & Johnson about a possible transaction to take over the Swiss drugmaker.

Continue Reading Below

"There can be no certainty that a transaction will result," Actelion said in a statement on Friday.

(Reporting by John Revill; editing by Brenna Hughes Neghaiwi)